Clinical Trial Update: Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 trial updates the efficacy and safety of DKF-313 in patients with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DKF-313

Snippet

Sponsor: Dongkook Pharmaceutical Co., Ltd. | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED